Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 66

1.

Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort Study.

Cabral DA, Canter DL, Muscal E, Nanda K, Wahezi DM, Spalding SJ, Twilt M, Benseler SM, Campillo S, Charuvanij S, Dancey P, Eberhard BA, Elder ME, Hersh A, Higgins GC, Huber AM, Khubchandani R, Kim S, Klein-Gitelman M, Kostik MM, Lawson EF, Lee T, Lubieniecka JM, McCurdy D, Moorthy LN, Morishita KA, Nielsen SM, O'Neil KM, Reiff A, Ristic G, Robinson AB, Sarmiento A, Shenoi S, Toth MB, Van Mater HA, Wagner-Weiner L, Weiss JE, White AJ, Yeung RS; ARChiVe Investigators Network within the PedVas Initiative..

Arthritis Rheumatol. 2016 Oct;68(10):2514-26. doi: 10.1002/art.39729.

PMID:
27111558
2.

Brief Report: Association of Myositis Autoantibodies, Clinical Features, and Environmental Exposures at Illness Onset With Disease Course in Juvenile Myositis.

Habers GE, Huber AM, Mamyrova G, Targoff IN, O'Hanlon TP, Adams S, Pandey JP, Boonacker C, van Brussel M, Miller FW, van Royen-Kerkhof A, Rider LG; Childhood Myositis Heterogeneity Study Group..

Arthritis Rheumatol. 2016 Mar;68(3):761-8. doi: 10.1002/art.39466.

3.

The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.

Rider LG, Shah M, Mamyrova G, Huber AM, Rice MM, Targoff IN, Miller FW; Childhood Myositis Heterogeneity Collaborative Study Group..

Medicine (Baltimore). 2013 Jul;92(4):223-43. doi: 10.1097/MD.0b013e31829d08f9.

4.

The clinical phenotypes of the juvenile idiopathic inflammatory myopathies.

Shah M, Mamyrova G, Targoff IN, Huber AM, Malley JD, Rice MM, Miller FW, Rider LG; Childhood Myositis Heterogeneity Collaborative Study Group..

Medicine (Baltimore). 2013 Jan;92(1):25-41. doi: 10.1097/MD.0b013e31827f264d.

5.

Weekend bias in Citizen Science data reporting: implications for phenology studies.

Courter JR, Johnson RJ, Stuyck CM, Lang BA, Kaiser EW.

Int J Biometeorol. 2013 Sep;57(5):715-20. doi: 10.1007/s00484-012-0598-7.

PMID:
23104424
6.

Do adult disease severity subclassifications predict use of cyclophosphamide in children with ANCA-associated vasculitis? An analysis of ARChiVe study treatment decisions.

Morishita K, Guzman J, Chira P, Muscal E, Zeft A, Klein-Gitelman M, Uribe AG, Abramson L, Benseler SM, Eberhard A, Ede K, Hashkes PJ, Hersh AO, Higgins G, Imundo LF, Jung L, Kim S, Kingsbury DJ, Lawson EF, Lee T, Li SC, Lovell DJ, Mason T, McCurdy D, O'Neil KM, Punaro M, Ramsey SE, Reiff A, Rosenkranz M, Schikler KN, Scuccimarri R, Singer NG, Stevens AM, van Mater H, Wahezi DM, White AJ, Cabral DA; ARChiVe Investigators Network..

J Rheumatol. 2012 Oct;39(10):2012-20. doi: 10.3899/jrheum.120299.

PMID:
22859342
7.

Increased sensitivity of the European medicines agency algorithm for classification of childhood granulomatosis with polyangiitis.

Uribe AG, Huber AM, Kim S, O'Neil KM, Wahezi DM, Abramson L, Baszis K, Benseler SM, Bowyer SL, Campillo S, Chira P, Hersh AO, Higgins GC, Eberhard A, Ede K, Imundo LF, Jung L, Kingsbury DJ, Klein-Gitelman M, Lawson EF, Li SC, Lovell DJ, Mason T, McCurdy D, Muscal E, Nassi L, Rabinovich E, Reiff A, Rosenkranz M, Schikler KN, Singer NG, Spalding S, Stevens AM, Cabral DA; ARegistry for Children with Vasculitis e-entry (ARChiVe) Network..

J Rheumatol. 2012 Aug;39(8):1687-97.

PMID:
22589257
8.

Assessing the performance of the Birmingham Vasculitis Activity Score at diagnosis for children with antineutrophil cytoplasmic antibody-associated vasculitis in A Registry for Childhood Vasculitis (ARChiVe).

Morishita K, Li SC, Muscal E, Spalding S, Guzman J, Uribe A, Abramson L, Baszis K, Benseler S, Bowyer S, Campillo S, Chira P, Hersh AO, Higgins G, Eberhard A, Ede K, Imundo L, Jung L, Kim S, Kingsbury DJ, Klein-Gitelman M, Lawson EF, Lovell DJ, Mason T, McCurdy D, Nanda K, Nassi L, O'Neil KM, Rabinovich E, Ramsey SE, Reiff A, Rosenkranz M, Schikler K, Stevens A, Wahezi D, Cabral DA; ARChiVe Investigators Network..

J Rheumatol. 2012 May;39(5):1088-94. doi: 10.3899/jrheum.111030.

PMID:
22337238
9.

Classification, presentation, and initial treatment of Wegener's granulomatosis in childhood.

Cabral DA, Uribe AG, Benseler S, O'Neil KM, Hashkes PJ, Higgins G, Zeft AS, Lovell DJ, Kingsbury DJ, Stevens A, McCurdy D, Chira P, Abramson L, Arkachaisri T, Campillo S, Eberhard A, Hersh AO, Huber AM, Kim S, Klein-Gitelman M, Levy DM, Li SC, Mason T, Dewitt EM, Muscal E, Nassi L, Reiff A, Schikler K, Singer NG, Wahezi D, Woodward A; ARChiVe (A Registry for Childhood Vasculitis: e-entry) Investigators Network..

Arthritis Rheum. 2009 Nov;60(11):3413-24. doi: 10.1002/art.24876.

10.

Cytokine gene polymorphisms as risk and severity factors for juvenile dermatomyositis.

Mamyrova G, O'Hanlon TP, Sillers L, Malley K, James-Newton L, Parks CG, Cooper GS, Pandey JP, Miller FW, Rider LG; Childhood Myositis Heterogeneity Collaborative Study Group..

Arthritis Rheum. 2008 Dec;58(12):3941-50. doi: 10.1002/art.24039.

11.

Corticosteroid treatment of refractory Kawasaki disease.

Lang BA, Yeung RS, Oen KG, Malleson PN, Huber AM, Riley M, Ebbeson R, Ramsey SE, Laxer RM, Silverman ED, McCrindle BW, Ratnapalan S, Feldman BM.

J Rheumatol. 2006 Apr;33(4):803-9.

PMID:
16583481
12.

Clinical responsiveness of self-report functional assessment measures for children with juvenile idiopathic arthritis undergoing intraarticular corticosteroid injections.

Brown GT, Wright FV, Lang BA, Birdi N, Oen K, Stephens D, McComas J, Feldman BM.

Arthritis Rheum. 2005 Dec 15;53(6):897-904.

13.

Pamidronate treatment of pediatric fracture patients on chronic steroid therapy.

Acott PD, Wong JA, Lang BA, Crocker JF.

Pediatr Nephrol. 2005 Mar;20(3):368-73.

PMID:
15690187
14.
15.

Bone mineral density in juvenile dermatomyositis: assessment using dual x-ray absorptiometry.

Stewart WA, Acott PD, Salisbury SR, Lang BA.

Arthritis Rheum. 2003 Aug;48(8):2294-8.

16.

Insecticidal proteins from Bacillus thuringiensis protect corn from corn rootworms.

Moellenbeck DJ, Peters ML, Bing JW, Rouse JR, Higgins LS, Sims L, Nevshemal T, Marshall L, Ellis RT, Bystrak PG, Lang BA, Stewart JL, Kouba K, Sondag V, Gustafson V, Nour K, Xu D, Swenson J, Zhang J, Czapla T, Schwab G, Jayne S, Stockhoff BA, Narva K, Schnepf HE, Stelman SJ, Poutre C, Koziel M, Duck N.

Nat Biotechnol. 2001 Jul;19(7):668-72.

PMID:
11433280
17.

Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: a multicenter cohort study.

Spiegel LR, Schneider R, Lang BA, Birdi N, Silverman ED, Laxer RM, Stephens D, Feldman BM.

Arthritis Rheum. 2000 Nov;43(11):2402-9.

18.

Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children.

Pachman LM, Hayford JR, Chung A, Daugherty CA, Pallansch MA, Fink CW, Gewanter HL, Jerath R, Lang BA, Sinacore J, Szer IS, Dyer AR, Hochberg MC.

J Rheumatol. 1998 Jun;25(6):1198-204.

PMID:
9632086
19.

New-onset juvenile dermatomyositis: comparisons with a healthy cohort and children with juvenile rheumatoid arthritis.

Pachman LM, Hayford JR, Hochberg MC, Pallansch MA, Chung A, Daugherty CD, Athreya BH, Bowyer SL, Fink CW, Gewanter HL, Jerath R, Lang BA, Szer IS, Sinacore J, Christensen ML, Dyer AR.

Arthritis Rheum. 1997 Aug;40(8):1526-33.

PMID:
9259435
20.

Supplemental Content

Loading ...
Support Center